IN SILICO AND IN VITRO ASSAY OF HGV ANALOGUE AS ANTIBACTERIAL
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2019, Vol 11, Issue 3
Abstract
Objective: The objective of this research was to design a new analogue compound, hexagamavunon (HGV). Methods: New design of analogue compound, HGV, was performed by QSAR study using BuildQSAR program. In this QSAR study, parameterized model (PM3) method using the Polak-Ribière algorithm was applied to calculate the optimal geometric structures of the used compounds. The new analogue compound, HGV had been synthesized using aldol condensation reaction. The assay of antibacterial activities was performed using the dilution method. Molecular operating environment (MOE) program was used for protocol docking. Results: The results of QSAR study reveal the good relationship of antibacterial activities. The in vitro antibacterial activities of 2,6-bis((E)-3,5-dibromo-4-hydroxybenzylidene) cyclohexan-1-one (A113) indicates the good potential to against S. aureus, B. subtilis and E. coli with IC50 27.3 μg/ml, 30.9 μg/ml, 32 μg/ml respectively. This is in accordance with the in silico evaluation showing that 2,6-bis((E)-3,5-dibromo-4-hydroxybenzylidene) cyclohexan-1-one has lower docking score than both amoxicillin and cefoxitin do as the native ligand of receptor 3MZE. Conclusion: Based on in silico and in vitro assay, 2,6-bis((E)-3,5-dibromo-4-hydroxybenzylidene) cyclohexan-1-one (A113) has good antibacterial activities against S. aureus, B. subtilis, and E. coli.
Authors and Affiliations
Bambang Wijianto, RITMALENI . , HARI PURNOMO, ARIEF NURROCHMAD
Keywords
Related Articles
- EP ID EP565427
- DOI 10.22159/ijpps.2019v11i3.30581
- Views 50
- Downloads 0
SESBANIA GRANDIFLORA: NEW NUTRACEUTICAL USE AS ANTIDIABETIC
Nutraceuticals are the emerging era in the treatment of diabetes mellitus, one of the seriously problematic due to leading the causes of death in all over the world. The newer anti-hyperglycemic drugs continue searching...
QUANTITATION OF AMLODIPINE IN HUMAN PLASMA BY LCMS/MS ASSAY
ÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂObjective: To develop and validate a simple, precise, and rapid liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for quantification of amlodipine in human plasma.Method...
LIQUISOLID COMPACTS: AN INNOVATIVE APPROACH FOR DISSOLUTION ENHANCEMENT
The challenge faced by the majority of the pharmaceutical products is the poor solubility of the drug candidates which leads to low bioavailability. Liquisolid compact is one of the emerging techniques that enhances the...
THE ASSOCIATION OF TYPE 2 DIABETES WITH OBESITY AND OTHER FACTORS: IN MULTINATIONAL COMMUNITY
Objective: Quantifying the influence of Obesity and other contributing factors on inducing Type 2 Diabetes is important to allow for rational planning and allocation of resources. Therefore, the major aim of this study w...
REMOVAL OF MALACHITE GREEN USING SILVER NANOPARTICLES VIA ADSORPTION AND CATALYTIC DEGRADATION
Objectives: The objectives of the present study were a) to optimize the parameters for the AgNPs synthesis using aqueous leaf extract of Aegle marmelos b) to evaluate the performance of AgNPs as nanosorbents of synthetic...